Advancing patient care

Overreliance on opioids in the postsurgical setting has set off a cascade of negative consequences, ranging from potentially severe adverse events to the risk of long-term use, misuse, and addiction.

Why we push for change

Redefining postsurgical pain management

Our flagship product, EXPAREL® (bupivacaine liposome injectable suspension), is a non-opioid medication administered at the time of surgery to control pain and reduce—or in some cases eliminate
—the need for opioids.

EXPAREL combines bupivacaine with the DepoFoam® drug delivery platform to provide long-lasting postsurgical pain control with a single intraoperative infiltration.

Our innovative, opioid-free alternatives